Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT06251323
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • iPATH implementation approach — OTHER
    A multi-level, multi-component, customized, standardized, technology enabled, person-centered, and team-based care practice transformation strategy.

Study Details

Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.

Key Dates

Start date
Sep 30, 2025
Status verified
Apr 2026
Primary completion
Jul 1, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
119,680 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Wave 1 Clinics
    Clinics will have data evaluated for up to 3 years. Wave 1 clinics will begin the iPATH practice transformation in Year 1.
  • Experimental: Wave 2 Clinics
    Clinics will have data evaluated for up to 3 years. Wave 2 clinics will begin the iPATH practice transformation in Year 2.

Primary Outcome Measure

Hemoglobin A1c [ Time Frame: Before and after 1-year practice transformation period ]

Locations (3)

FacilityCityStateZIPSite coordinators
Board of Trustees of the Leland Stanford Junior UniversityStanfordCalifornia94305
Sara Singer, PhD
[email protected]
650-498-5354
President and Fellows of Harvard College, T.H. Chan SchoolBostonMassachusetts02115
Michaela Kerrissey, PhD
[email protected]
617-432-4520
The Ohio State UniversityColumbusOhio43210
Daniel Walker, PhD
[email protected]
614-293-2428

Find similar trials in Stanford, CA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Board of Trustees of the Leland Stanford Junior University· Stanford, CAPresident and Fellows of Harvard College, T.H. Chan School· Boston, MAThe Ohio State University· Columbus, OH

Related Studies